Mice lacking C5 or treated with GalNAc-C5-siRNA or anti-C5 inhibitory antibody do not develop arthritis (15, 16, 74) despite the presence of MASP-1 and MASP-2. This evidence concerns the gene C5 and arthritic joint disease.